CN106771237B - 一种检测猪萨佩罗病毒抗体的elisa试剂盒 - Google Patents
一种检测猪萨佩罗病毒抗体的elisa试剂盒 Download PDFInfo
- Publication number
- CN106771237B CN106771237B CN201611145457.7A CN201611145457A CN106771237B CN 106771237 B CN106771237 B CN 106771237B CN 201611145457 A CN201611145457 A CN 201611145457A CN 106771237 B CN106771237 B CN 106771237B
- Authority
- CN
- China
- Prior art keywords
- virus
- antibody
- porcine
- kit
- porcine sapelo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000008157 ELISA kit Methods 0.000 title claims abstract description 12
- 241001333903 Sapelovirus A Species 0.000 title claims description 35
- 238000001514 detection method Methods 0.000 claims abstract description 23
- 241000700605 Viruses Species 0.000 claims abstract description 22
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims abstract description 6
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims abstract description 6
- 102000036639 antigens Human genes 0.000 claims abstract description 5
- 108091007433 antigens Proteins 0.000 claims abstract description 5
- 208000015181 infectious disease Diseases 0.000 claims abstract description 4
- 210000002966 serum Anatomy 0.000 claims description 23
- 239000000243 solution Substances 0.000 claims description 15
- 241000282898 Sus scrofa Species 0.000 claims description 12
- 239000013642 negative control Substances 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 239000013612 plasmid Substances 0.000 claims description 6
- 239000013604 expression vector Substances 0.000 claims description 5
- 230000014509 gene expression Effects 0.000 claims description 5
- 239000013641 positive control Substances 0.000 claims description 5
- 239000000758 substrate Substances 0.000 claims description 5
- 238000012360 testing method Methods 0.000 claims description 5
- 239000002299 complementary DNA Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 230000009465 prokaryotic expression Effects 0.000 claims description 4
- 238000010839 reverse transcription Methods 0.000 claims description 4
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 238000010790 dilution Methods 0.000 claims description 2
- 239000012895 dilution Substances 0.000 claims description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 238000004140 cleaning Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229940005654 nitrite ion Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 8
- 238000002965 ELISA Methods 0.000 abstract description 6
- 241000282887 Suidae Species 0.000 abstract description 5
- 239000000427 antigen Substances 0.000 abstract description 4
- 238000003745 diagnosis Methods 0.000 abstract description 3
- 238000011835 investigation Methods 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 230000000405 serological effect Effects 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 101150024766 VP1 gene Proteins 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 238000003259 recombinant expression Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000012089 stop solution Substances 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- 241000283707 Capra Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 108010061238 threonyl-glycine Proteins 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- GFBLJMHGHAXGNY-ZLUOBGJFSA-N Ala-Asn-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O GFBLJMHGHAXGNY-ZLUOBGJFSA-N 0.000 description 1
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 1
- IPZQNYYAYVRKKK-FXQIFTODSA-N Ala-Pro-Ala Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O IPZQNYYAYVRKKK-FXQIFTODSA-N 0.000 description 1
- VQAVBBCZFQAAED-FXQIFTODSA-N Ala-Pro-Asn Chemical compound C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N)C(=O)O)N VQAVBBCZFQAAED-FXQIFTODSA-N 0.000 description 1
- KUFVXLQLDHJVOG-SHGPDSBTSA-N Ala-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C)N)O KUFVXLQLDHJVOG-SHGPDSBTSA-N 0.000 description 1
- NLYYHIKRBRMAJV-AEJSXWLSSA-N Ala-Val-Pro Chemical compound C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N NLYYHIKRBRMAJV-AEJSXWLSSA-N 0.000 description 1
- VBFJESQBIWCWRL-DCAQKATOSA-N Arg-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VBFJESQBIWCWRL-DCAQKATOSA-N 0.000 description 1
- JGDGLDNAQJJGJI-AVGNSLFASA-N Arg-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)N JGDGLDNAQJJGJI-AVGNSLFASA-N 0.000 description 1
- WVNFNPGXYADPPO-BQBZGAKWSA-N Arg-Gly-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O WVNFNPGXYADPPO-BQBZGAKWSA-N 0.000 description 1
- NGYHSXDNNOFHNE-AVGNSLFASA-N Arg-Pro-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O NGYHSXDNNOFHNE-AVGNSLFASA-N 0.000 description 1
- VUGWHBXPMAHEGZ-SRVKXCTJSA-N Arg-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCN=C(N)N VUGWHBXPMAHEGZ-SRVKXCTJSA-N 0.000 description 1
- YNSUUAOAFCVINY-OSUNSFLBSA-N Arg-Thr-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YNSUUAOAFCVINY-OSUNSFLBSA-N 0.000 description 1
- GKKUBLFXKRDMFC-BQBZGAKWSA-N Asn-Pro-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O GKKUBLFXKRDMFC-BQBZGAKWSA-N 0.000 description 1
- HPBNLFLSSQDFQW-WHFBIAKZSA-N Asn-Ser-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O HPBNLFLSSQDFQW-WHFBIAKZSA-N 0.000 description 1
- WLVLIYYBPPONRJ-GCJQMDKQSA-N Asn-Thr-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O WLVLIYYBPPONRJ-GCJQMDKQSA-N 0.000 description 1
- LRCIOEVFVGXZKB-BZSNNMDCSA-N Asn-Tyr-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LRCIOEVFVGXZKB-BZSNNMDCSA-N 0.000 description 1
- SYZWMVSXBZCOBZ-QXEWZRGKSA-N Asn-Val-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)N)N SYZWMVSXBZCOBZ-QXEWZRGKSA-N 0.000 description 1
- QHAJMRDEWNAIBQ-FXQIFTODSA-N Asp-Arg-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O QHAJMRDEWNAIBQ-FXQIFTODSA-N 0.000 description 1
- HOBNTSHITVVNBN-ZPFDUUQYSA-N Asp-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N HOBNTSHITVVNBN-ZPFDUUQYSA-N 0.000 description 1
- YFSLJHLQOALGSY-ZPFDUUQYSA-N Asp-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N YFSLJHLQOALGSY-ZPFDUUQYSA-N 0.000 description 1
- BPAUXFVCSYQDQX-JRQIVUDYSA-N Asp-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)O)N)O BPAUXFVCSYQDQX-JRQIVUDYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- UWZLBXOBVKRUFE-HGNGGELXSA-N Gln-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCC(=O)N)N UWZLBXOBVKRUFE-HGNGGELXSA-N 0.000 description 1
- XFKUFUJECJUQTQ-CIUDSAMLSA-N Gln-Gln-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XFKUFUJECJUQTQ-CIUDSAMLSA-N 0.000 description 1
- BJPPYOMRAVLXBY-YUMQZZPRSA-N Gln-Met-Gly Chemical compound CSCC[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)N)N BJPPYOMRAVLXBY-YUMQZZPRSA-N 0.000 description 1
- FITIQFSXXBKFFM-NRPADANISA-N Gln-Val-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O FITIQFSXXBKFFM-NRPADANISA-N 0.000 description 1
- JRCUFCXYZLPSDZ-ACZMJKKPSA-N Glu-Asp-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O JRCUFCXYZLPSDZ-ACZMJKKPSA-N 0.000 description 1
- SOYWRINXUSUWEQ-DLOVCJGASA-N Glu-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCC(O)=O SOYWRINXUSUWEQ-DLOVCJGASA-N 0.000 description 1
- PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 1
- MZZSCEANQDPJER-ONGXEEELSA-N Gly-Ala-Phe Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MZZSCEANQDPJER-ONGXEEELSA-N 0.000 description 1
- LJPIRKICOISLKN-WHFBIAKZSA-N Gly-Ala-Ser Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O LJPIRKICOISLKN-WHFBIAKZSA-N 0.000 description 1
- JVACNFOPSUPDTK-QWRGUYRKSA-N Gly-Asn-Phe Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JVACNFOPSUPDTK-QWRGUYRKSA-N 0.000 description 1
- KQDMENMTYNBWMR-WHFBIAKZSA-N Gly-Asp-Ala Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O KQDMENMTYNBWMR-WHFBIAKZSA-N 0.000 description 1
- QPTNELDXWKRIFX-YFKPBYRVSA-N Gly-Gly-Gln Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O QPTNELDXWKRIFX-YFKPBYRVSA-N 0.000 description 1
- ZOTGXWMKUFSKEU-QXEWZRGKSA-N Gly-Ile-Met Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(O)=O ZOTGXWMKUFSKEU-QXEWZRGKSA-N 0.000 description 1
- MIIVFRCYJABHTQ-ONGXEEELSA-N Gly-Leu-Val Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O MIIVFRCYJABHTQ-ONGXEEELSA-N 0.000 description 1
- NTBOEZICHOSJEE-YUMQZZPRSA-N Gly-Lys-Ser Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O NTBOEZICHOSJEE-YUMQZZPRSA-N 0.000 description 1
- OHUKZZYSJBKFRR-WHFBIAKZSA-N Gly-Ser-Asp Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O OHUKZZYSJBKFRR-WHFBIAKZSA-N 0.000 description 1
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 1
- LCRDMSSAKLTKBU-ZDLURKLDSA-N Gly-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN LCRDMSSAKLTKBU-ZDLURKLDSA-N 0.000 description 1
- RHRLHXQWHCNJKR-PMVVWTBXSA-N Gly-Thr-His Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 RHRLHXQWHCNJKR-PMVVWTBXSA-N 0.000 description 1
- 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
- YVCGJPIKRMGNPA-LSJOCFKGSA-N His-Met-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O YVCGJPIKRMGNPA-LSJOCFKGSA-N 0.000 description 1
- VIJMRAIWYWRXSR-CIUDSAMLSA-N His-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 VIJMRAIWYWRXSR-CIUDSAMLSA-N 0.000 description 1
- UNDGQKWQNSTPPW-CYDGBPFRSA-N Ile-Arg-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCSC)C(=O)O)N UNDGQKWQNSTPPW-CYDGBPFRSA-N 0.000 description 1
- QYZYJFXHXYUZMZ-UGYAYLCHSA-N Ile-Asn-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N QYZYJFXHXYUZMZ-UGYAYLCHSA-N 0.000 description 1
- PJLLMGWWINYQPB-PEFMBERDSA-N Ile-Asn-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N PJLLMGWWINYQPB-PEFMBERDSA-N 0.000 description 1
- WZDCVAWMBUNDDY-KBIXCLLPSA-N Ile-Glu-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O)N WZDCVAWMBUNDDY-KBIXCLLPSA-N 0.000 description 1
- XLXPYSDGMXTTNQ-DKIMLUQUSA-N Ile-Phe-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(O)=O XLXPYSDGMXTTNQ-DKIMLUQUSA-N 0.000 description 1
- XLXPYSDGMXTTNQ-UHFFFAOYSA-N Ile-Phe-Leu Natural products CCC(C)C(N)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=CC=C1 XLXPYSDGMXTTNQ-UHFFFAOYSA-N 0.000 description 1
- WLRJHVNFGAOYPS-HJPIBITLSA-N Ile-Ser-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N WLRJHVNFGAOYPS-HJPIBITLSA-N 0.000 description 1
- QGXQHJQPAPMACW-PPCPHDFISA-N Ile-Thr-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)O)N QGXQHJQPAPMACW-PPCPHDFISA-N 0.000 description 1
- BZUOLKFQVVBTJY-SLBDDTMCSA-N Ile-Trp-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)N)C(=O)O)N BZUOLKFQVVBTJY-SLBDDTMCSA-N 0.000 description 1
- HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 1
- GPICTNQYKHHHTH-GUBZILKMSA-N Leu-Gln-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O GPICTNQYKHHHTH-GUBZILKMSA-N 0.000 description 1
- YWKNKRAKOCLOLH-OEAJRASXSA-N Leu-Phe-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=CC=C1 YWKNKRAKOCLOLH-OEAJRASXSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- MPOHDJKRBLVGCT-CIUDSAMLSA-N Lys-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N MPOHDJKRBLVGCT-CIUDSAMLSA-N 0.000 description 1
- GILLQRYAWOMHED-DCAQKATOSA-N Lys-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN GILLQRYAWOMHED-DCAQKATOSA-N 0.000 description 1
- SJDQOYTYNGZZJX-SRVKXCTJSA-N Met-Glu-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O SJDQOYTYNGZZJX-SRVKXCTJSA-N 0.000 description 1
- LRALLISKBZNSKN-BQBZGAKWSA-N Met-Gly-Ser Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LRALLISKBZNSKN-BQBZGAKWSA-N 0.000 description 1
- XPVCDCMPKCERFT-GUBZILKMSA-N Met-Ser-Arg Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O XPVCDCMPKCERFT-GUBZILKMSA-N 0.000 description 1
- XTSBLBXAUIBMLW-KKUMJFAQSA-N Met-Tyr-Glu Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N XTSBLBXAUIBMLW-KKUMJFAQSA-N 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- DPUOLKQSMYLRDR-UBHSHLNASA-N Phe-Arg-Ala Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 DPUOLKQSMYLRDR-UBHSHLNASA-N 0.000 description 1
- NKLDZIPTGKBDBB-HTUGSXCWSA-N Phe-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)N)O NKLDZIPTGKBDBB-HTUGSXCWSA-N 0.000 description 1
- MFQXSDWKUXTOPZ-DZKIICNBSA-N Phe-Gln-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)N MFQXSDWKUXTOPZ-DZKIICNBSA-N 0.000 description 1
- MJQFZGOIVBDIMZ-WHOFXGATSA-N Phe-Ile-Gly Chemical compound N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)O MJQFZGOIVBDIMZ-WHOFXGATSA-N 0.000 description 1
- VGTJSEYTVMAASM-RPTUDFQQSA-N Phe-Thr-Tyr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O VGTJSEYTVMAASM-RPTUDFQQSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 241000702619 Porcine parvovirus Species 0.000 description 1
- IFMDQWDAJUMMJC-DCAQKATOSA-N Pro-Ala-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O IFMDQWDAJUMMJC-DCAQKATOSA-N 0.000 description 1
- VWXGFAIZUQBBBG-UWVGGRQHSA-N Pro-His-Gly Chemical compound C([C@@H](C(=O)NCC(=O)[O-])NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 VWXGFAIZUQBBBG-UWVGGRQHSA-N 0.000 description 1
- DSGSTPRKNYHGCL-JYJNAYRXSA-N Pro-Phe-Met Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(O)=O DSGSTPRKNYHGCL-JYJNAYRXSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- WXUBSIDKNMFAGS-IHRRRGAJSA-N Ser-Arg-Tyr Chemical compound NC(N)=NCCC[C@H](NC(=O)[C@H](CO)N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WXUBSIDKNMFAGS-IHRRRGAJSA-N 0.000 description 1
- BTPAWKABYQMKKN-LKXGYXEUSA-N Ser-Asp-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BTPAWKABYQMKKN-LKXGYXEUSA-N 0.000 description 1
- IOVBCLGAJJXOHK-SRVKXCTJSA-N Ser-His-His Chemical compound C([C@H](NC(=O)[C@H](CO)N)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 IOVBCLGAJJXOHK-SRVKXCTJSA-N 0.000 description 1
- RXSWQCATLWVDLI-XGEHTFHBSA-N Ser-Met-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RXSWQCATLWVDLI-XGEHTFHBSA-N 0.000 description 1
- JAWGSPUJAXYXJA-IHRRRGAJSA-N Ser-Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)N)CC1=CC=CC=C1 JAWGSPUJAXYXJA-IHRRRGAJSA-N 0.000 description 1
- PURRNJBBXDDWLX-ZDLURKLDSA-N Ser-Thr-Gly Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CO)N)O PURRNJBBXDDWLX-ZDLURKLDSA-N 0.000 description 1
- SGZVZUCRAVSPKQ-FXQIFTODSA-N Ser-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CO)N SGZVZUCRAVSPKQ-FXQIFTODSA-N 0.000 description 1
- MQCPGOZXFSYJPS-KZVJFYERSA-N Thr-Ala-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MQCPGOZXFSYJPS-KZVJFYERSA-N 0.000 description 1
- GZYNMZQXFRWDFH-YTWAJWBKSA-N Thr-Arg-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N)O GZYNMZQXFRWDFH-YTWAJWBKSA-N 0.000 description 1
- AQAMPXBRJJWPNI-JHEQGTHGSA-N Thr-Gly-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AQAMPXBRJJWPNI-JHEQGTHGSA-N 0.000 description 1
- FQPDRTDDEZXCEC-SVSWQMSJSA-N Thr-Ile-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O FQPDRTDDEZXCEC-SVSWQMSJSA-N 0.000 description 1
- NQQMWWVVGIXUOX-SVSWQMSJSA-N Thr-Ser-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NQQMWWVVGIXUOX-SVSWQMSJSA-N 0.000 description 1
- WKGAAMOJPMBBMC-IXOXFDKPSA-N Thr-Ser-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WKGAAMOJPMBBMC-IXOXFDKPSA-N 0.000 description 1
- 208000026062 Tissue disease Diseases 0.000 description 1
- JWHOIHCOHMZSAR-QWRGUYRKSA-N Tyr-Asp-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JWHOIHCOHMZSAR-QWRGUYRKSA-N 0.000 description 1
- FNWGDMZVYBVAGJ-XEGUGMAKSA-N Tyr-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC1=CC=C(C=C1)O)N FNWGDMZVYBVAGJ-XEGUGMAKSA-N 0.000 description 1
- GYBVHTWOQJMYAM-HRCADAONSA-N Tyr-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N GYBVHTWOQJMYAM-HRCADAONSA-N 0.000 description 1
- CDBXVDXSLPLFMD-BPNCWPANSA-N Tyr-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC1=CC=C(O)C=C1 CDBXVDXSLPLFMD-BPNCWPANSA-N 0.000 description 1
- MQGGXGKQSVEQHR-KKUMJFAQSA-N Tyr-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MQGGXGKQSVEQHR-KKUMJFAQSA-N 0.000 description 1
- ITDWWLTTWRRLCC-KJEVXHAQSA-N Tyr-Thr-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 ITDWWLTTWRRLCC-KJEVXHAQSA-N 0.000 description 1
- HHSILIQTHXABKM-YDHLFZDLSA-N Val-Asp-Phe Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O HHSILIQTHXABKM-YDHLFZDLSA-N 0.000 description 1
- NXRAUQGGHPCJIB-RCOVLWMOSA-N Val-Gly-Asn Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O NXRAUQGGHPCJIB-RCOVLWMOSA-N 0.000 description 1
- MIAZWUMFUURQNP-YDHLFZDLSA-N Val-Tyr-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N MIAZWUMFUURQNP-YDHLFZDLSA-N 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 1
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 208000032625 disorder of ear Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000011841 epidemiological investigation Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- 210000003000 inclusion body Anatomy 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 108010091871 leucylmethionine Proteins 0.000 description 1
- 108010009298 lysylglutamic acid Proteins 0.000 description 1
- 108010038320 lysylphenylalanine Proteins 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 108010016686 methionyl-alanyl-serine Proteins 0.000 description 1
- 108010068488 methionylphenylalanine Proteins 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 208000008494 pericarditis Diseases 0.000 description 1
- 108010018625 phenylalanylarginine Proteins 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108010004914 prolylarginine Proteins 0.000 description 1
- 108010029020 prolylglycine Proteins 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 208000012153 swine disease Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 108010051110 tyrosyl-lysine Proteins 0.000 description 1
- 108010003137 tyrosyltyrosine Proteins 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
一种检测猪萨佩罗病毒抗体的ELISA试剂盒,其是以纯化的猪萨佩罗病毒VP1重组蛋白作为抗原,首次建立检测PSV抗体的ELISA方法并组装成试剂盒,可对目前我国流行的PSV病毒进行有效的血清学诊断和调查,判断猪群中PSV抗体水平和自然感染的状况,为PSV病毒的防制提供一种快速、简便的检测方法。
Description
技术领域
本发明属于兽医生物技术领域,具体涉及一种检测猪萨佩罗病毒抗体的ELISA试剂盒,能用于猪萨佩罗病毒抗体检测及猪萨佩罗病毒感染的判断。
背景技术
猪萨佩罗病毒(Porcine Sapelovirus,PSV)可引起猪脑脊髓灰质炎、肺炎、繁殖障碍、心包炎、心肌炎、皮肤损伤、腹泻等多系统综合征。PSV能在猪肠道上皮细胞繁殖,并随粪便排出体外,感染猪只康复后依然会继续排毒,使该病毒在环境中大量存在,成为重要的病毒传染源。PSV还能和猪流行性腹泻、猪瘟、猪蓝耳病、猪细小等常见猪疫病病原相互作用,加重该些病的危害。
PSV的实验室诊断方法主要包括病理组织学检测、病毒的分离与鉴定、RT-PCR等,但这些方法主要用于检测病原,且对试验条件和技术要求较高,不适合高通量检测。
目前还没有关于猪萨佩罗病毒抗体检测方法的报道,本发明利用分子生物学基因克隆表达技术,获得PSV病毒VP1重组蛋白,以其作为抗原首次建立检测PSV抗体的ELISA方法并组装成试剂盒,可对目前我国流行的PSV病毒进行有效的血清学诊断和调查,判断猪群中PSV抗体水平和自然感染的状况,为PSV病毒的防制提供一种快速、简便的检测方法。
发明内容
本发明所要解决的技术问题是:针对上述现有技术的不足,提供一种快速、准确、简便、适于大批量检测猪萨佩罗病毒抗体的ELISA试剂盒,以便于猪萨佩罗病毒感染的诊断及流行病学调查。
为解决上述技术问题,本发明所采用的技术方案是:一种检测猪萨佩罗病毒抗体的ELISA试剂盒,其特点是,所述试剂盒内含有猪萨佩罗病毒VP1抗原蛋白。
所述猪萨佩罗病毒VP1抗原蛋白为纯化的利用重组原核表达载体质粒pET-28a-VP1表达的重组蛋白,其氨基酸序列如SEQ ID No:1所示。
所述试剂盒内设有猪萨佩罗病毒抗体检测板条,该检测板条为包被猪萨佩罗病毒VP1抗原蛋白的96孔酶标板。
所述试剂盒内还设有阴性对照血清、阳性对照血清、血清稀释液、酶标二抗、洗涤液、底物显色液及终止液。其中,所述阴性对照血清为没有感染猪萨佩罗病毒的健康猪血清,阳性血清为接种猪萨佩罗病毒后采集的猪血清;所述酶标二抗为辣根过氧化物酶标记的羊抗猪IgG。
本发明的试剂盒,能用于PSV抗体检测,弥补了PSV抗体检测方法的空白;具有检测通量大、结果确切、灵敏度高、操作简单的特点,易于基层推广。
附图说明
图1是PSV VP1基因的PCR产物电泳图。
其中,1为阴性对照;2为VP1基因扩增产物;M为DNA分子量标准。
图2是PSV重组VP1蛋白的表达电泳图。
其中,M为蛋白分子量标准;1为阴性对照菌全菌;2为重组表达菌上清;3为重组表达菌沉淀。
图3是纯化的PSV重组VP1蛋白的电泳图。
其中,1为纯化的重组VP1蛋白;M为蛋白分子量标准。
具体实施方式
实施例1PSV重组VP1蛋白的制备
1)猪萨佩罗病毒RNA提取及反转录:用病毒RNA提取试剂盒(北京天恩泽公司),按说明书操作从组织病料中提取猪萨佩罗病毒RNA。以所提取的RNA为模板,用反转录试剂盒(美国Theremo公司),按说明书操作获得cDNA。
2)猪萨佩罗病毒VP1基因的克隆:根据GenBank中猪萨佩罗病毒的基因序列(登录号:KX354740)设计两条引物,上游引物(Fp)为:CGCGGATCCGGGGATATAAAAGAAGTGGTGCA(SEQID No:2);下游引物(Rp)为:CCCAAGCTTCTATTGAGTTGCAGGGTAATATCT(SEQ ID No:3),两引物序列中下划线分别表示BamH I和Hind III酶切位点,以上述反转录成的cDNA为模板,通过PCR方法扩增VP1基因。PCR体系含10μL 5×Buffer、4μL dNTP、1μL Fp、1μL Rp、1μL高保真DNA聚合酶、2μL模板及23μL灭菌超纯水;PCR条件为:94℃预变性5min,94℃变性30s,61℃退火30s,72℃延伸40s,35个循环。反应完后取6μL PCR产物进行1%琼脂糖凝胶电泳检测。扩增片段经电泳检测,结果见图1,扩增片段大小与预期目的片段大小相符。
3)重组表达质粒的构建:将扩增的PCR产物和和pET28-a(+)载体分别经BamH I和Hind III酶切,37℃恒温箱中反应2h,回收各自的酶切片段,用T4DNA连接酶连接,连接体系为:1μL载体酶切产物、7μL目的基因酶切产物、1μL 10×T4连接Buffer及1μL T4连接酶,将配好的体系置于16℃水浴中12h。将连接产物转化至大肠杆菌JM109感受态中,提取质粒,酶切鉴定阳性克隆,将鉴定为阳性克隆的质粒送华大公司基因公司进行序列测定。测序结果表明VP1基因片段已于BamH I和Hind III酶切位点之间与pET-28a(+)载体正确相连,表达蛋白的阅读框正确,说明重组原核表达载体质粒pET28a-VP1构建成功。
4)重组蛋白的表达:将pET28a-VP1重组表达载体转化至大肠杆菌BL21(DE3)中,转化过程为:取5ul连接产物,加入到100ul上述大肠杆菌BL21(DE3)感受态细胞中,冰浴30min,42℃热冲击90s,再冰浴2min,于超净工作台中加入700ul LB培养基,于37℃180rmp/min摇床中摇菌45min后3000rmp离心3min,留100ul上清重悬菌泥,取菌液涂布于含卡那霉素30μg/mL的LB琼脂平板上,置于37℃恒温箱中培养24h后,挑取单克隆菌落,参照Novagen公司pET Syetem Manual表达重组VP1融合蛋白,并用SDS-PAGE电泳检测目的蛋白,显示重组VP1蛋白主要以包涵体形式表达(图2),其氨基酸序列如SEQ ID No:1所示。
5)重组蛋白的纯化:使用His标签蛋白纯化试剂盒(Novagen公司产品),参照使用说明书,对重组VP1蛋白进行纯化,并用SDS-PAGE电泳检测,见图3,结果表明重组VP1蛋白获得纯化。
实施例2检测PSV抗体的ELISA试剂盒的制备
1)抗体检测板条:每个试剂盒包含2块ELISA板,每块板含可拆卸的已包被检测抗原的ELISA板条,规格为8孔×12条。
ELISA板条(抗原板)的制备:用0.05M碳酸盐缓冲液(pH9.6)稀释实施例1中得到的纯化的VP1融合蛋白,用方阵法确定最佳包被浓度为2.5μg/ml,取可拆96孔酶标板,每孔加入100μl,4℃包被24小时后用含0.05%吐温-20(体积比)的PBS(pH7.4)洗涤液(PBST)洗涤2次,用5%脱脂奶粉(质量体积比)37℃封闭1小时,用PBST充分洗涤,室温风干。
2)阴、阳性对照血清(各1.5mL):阴性血清为没有感染PSV的健康猪血清,阳性血清为接种PSV病毒后采集的猪血清。
3)血清稀释液(60mL):1%BSA,由10g牛血清白蛋白BSA加800mL PBST溶解,加灭菌水至1000mL配制成。
4)酶标二抗(30mL):将辣根过氧化物酶标记的羊抗猪IgG用含1%BSA的PBST稀释10000倍,做为直接使用浓度的酶标二抗。
5)洗涤液(75mL):10倍浓缩的含0.5%吐温-20的1M PBS(pH7.4)。
6)底物显色液(15mL):以双蒸水定容至1000ml,配置显色液A。称取9.33g柠檬酸、14.6g磷酸氢二钠(Na2HPO4·12H2O)、6.4ml 0.75%过氧化氢尿素,混匀,调pH值到5.0-5.4,加双蒸水定容至1000ml,配制显色液B。显色液A、B等体积混合,即为底物显色液。
7)终止液(15mL):2M H2SO4。
实施例3PSV抗体检测试剂盒的使用
a.将待检血清样品用血清稀释液100倍稀释后,取100μl加至抗体检测板,阳性和阴性对照血清不用稀释,直接加100μl,且重复两孔,置37℃孵育30分钟后弃去孔内液体,每孔用250-300μl洗涤液洗涤4次。
b.每孔加入100μl的酶标二抗,将酶标板置于37℃孵育30分钟后弃去孔内液体,每孔用250-300μl洗涤液洗涤4次。
c.加入底物显色液,每孔50μl,37℃避光显色15分钟。
d.加入终止液,每孔50μl,终止显色。
e.用酶标仪在450nm波长下读取OD值,并计算样品的S/P值,S/P值=(样品OD450值―阴性对照平均OD450值)/(阳性对照平均OD450值―阴性对照平均OD450值)。根据判定标准确定待检样品的阴、阳性结果。
PSV抗体检测试剂盒的判定标准:用PSV抗体检测试剂盒检测40份阴性血清,计算其平均S/P值(X)为0.183,标准差(SD)为0.039,根据统计学原理,确定阴、阳性结果的临界值=X+3SD=0.3,即当S/P≥0.3,样品为抗PSV抗体阳性,当S/P<0.3,样品为抗PSV抗体阴性。
实施例4应用本试剂盒对临床样品进行抗体检测
应用本发明的PSV抗体检测试剂盒对来自湖南省8个猪场的368份临床猪血清样品进行检测,结果见表1。该检测结果显示临床上A~H 8个猪场的抗体阳性率在29.17%~62.50%之间,平均抗体阳性率52.17%,表明本试剂盒能用于大批量PSV抗体的快速检测。
表1 A-H猪场血清样品检测结果
猪场 | 检测样品数(份) | 阳性数(份) | 阳性率 |
A | 24 | 11 | 45.83% |
B | 24 | 7 | 29.17% |
C | 48 | 27 | 56.25% |
D | 40 | 15 | 37.50% |
E | 48 | 22 | 45.83% |
F | 40 | 25 | 62.50% |
G | 48 | 26 | 54.17% |
H | 96 | 59 | 61.46% |
共计 | 368 | 192 | 52.17% |
SEQUENCE LISTING
<110> 湖南农业大学;湖南康保特生物科技有限公司
<120> 一种检测猪萨佩罗病毒抗体的ELISA试剂盒
<160> 3
<170> PatentIn version 3.3
<210> 1
<211> 318
<212> PRT
<213> 合成
<400> 1
Met Gly Ser Ser His His His His His His Ser Ser Gly Leu Val Pro
1 5 10 15
Arg Gly Ser His Met Ala Ser Met Thr Gly Gly Gln Gln Met Gly Arg
20 25 30
Gly Ser Gly Asp Ile Lys Glu Val Val Gln Ala His Ile Asn Asn Thr
35 40 45
Leu Gln Ser Ala Leu Thr Thr Arg Pro Gln Gln Glu Gln Val Ser Asn
50 55 60
Gly Ile Met Ile Asn Gln Gly Asp Ala Pro Ala Leu Gly Ala Ala Glu
65 70 75 80
Thr Gly Glu Ser Asp Thr Asn Ser Gly Gly Ser Thr Met Glu Leu Gln
85 90 95
Ala Thr Asn Cys Val Phe Ser Leu Arg Glu Thr Asp Leu Glu Tyr Leu
100 105 110
Met Ser Arg Tyr Ser Leu Met Tyr Glu Asp Ile Leu Asp Tyr Thr Ser
115 120 125
Ser Thr Gly Arg Arg His Leu Val Tyr Asn Val Asp Phe Arg Thr Ile
130 135 140
Gly Lys Ser Gly Ser Asp Ile Thr Lys Phe Arg Ala Phe Thr Tyr Trp
145 150 155 160
Arg Phe Asp Leu Asp Val Val Val Met Met Leu Glu Asp Lys Ala Ser
165 170 175
Lys Val Ser Asn Val Met Phe Gln Val Leu Phe Thr Pro His Gly Gly
180 185 190
Ala Val Pro Gly Thr His Asn Thr Ala Ile Trp Asn Ala Pro Asn Ser
195 200 205
Thr Ser Ile Tyr Thr Arg Val Gly Asn Ala Pro Ala Ser Phe Arg Ile
210 215 220
Pro Phe Met Ser Val Cys Asn Tyr Tyr Thr Ser Phe Tyr Asp Gly Asp
225 230 235 240
Gly Asn Phe Asp Arg Asn Gly Ala Ser Tyr Gly Ile Asn Pro Gly Asn
245 250 255
Phe Ile Gly Thr Ile Ser Ile Arg Met Ala Asn Asp Phe Gln Thr Asp
260 265 270
Ala Thr Thr Gly Ala Phe Arg Ala Lys Ile Phe Leu Arg Pro Val Asn
275 280 285
Ile Glu Ala Tyr Met Pro Arg Pro Leu Ile Ser Tyr Lys Ala Asn Gly
290 295 300
Thr Ala Arg Glu Asp Ser Ser Arg Tyr Tyr Pro Ala Thr Gln
305 310 315
<210> 2
<211> 32
<212> DNA
<213> 人工合成
<400> 2
cgcggatccg gggatataaa agaagtggtg ca 32
<210> 3
<211> 33
<212> DNA
<213> 人工合成
<400> 3
cccaagcttc tattgagttg cagggtaata tct 33
Claims (5)
1.一种检测猪萨佩罗病毒抗体的ELISA试剂盒,其特征在于,所述试剂盒内含有猪萨佩罗病毒VP1抗原蛋白,该猪萨佩罗病毒VP1抗原蛋白为纯化的利用重组原核表达载体质粒pET-28a-VP1表达的重组蛋白,其氨基酸序列如SEQ ID No:1所示;具体制备过程如下:
1)提取猪萨佩罗病毒RNA,反转录成cDNA;
2)根据猪萨佩罗病毒的基因序列设计SEQ ID No:2和SEQ ID No:3所示的引物,以反转录成的cDNA为模板进行扩增;
3)将扩增产物与pET28-a(+)载体进行连接,构建重组原核表达载体质粒pET28a-VP1,表达后进行纯化。
2.如权利要求1所述的一种检测猪萨佩罗病毒抗体的ELISA试剂盒,其特征在于,所述试剂盒内设有猪萨佩罗病毒抗体检测板条,该检测板条为包被猪萨佩罗病毒VP1抗原蛋白的96孔酶标板。
3.如权利要求1所述的一种检测猪萨佩罗病毒抗体的ELISA试剂盒,其特征在于,所述试剂盒内还设有阴性对照血清、阳性对照血清、血清稀释液、酶标二抗、洗涤液、底物显色液及终止液。
4.如权利要求3所述的一种检测猪萨佩罗病毒抗体的ELISA试剂盒,其特征在于,所述阴性对照血清为没有感染猪萨佩罗病毒的健康猪血清,阳性血清为接种猪萨佩罗病毒后采集的猪血清。
5.如权利要求3所述的一种检测猪萨佩罗病毒抗体的ELISA试剂盒,其特征在于,所述酶标二抗为辣根过氧化物酶标记的羊抗猪IgG。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611145457.7A CN106771237B (zh) | 2016-12-13 | 2016-12-13 | 一种检测猪萨佩罗病毒抗体的elisa试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611145457.7A CN106771237B (zh) | 2016-12-13 | 2016-12-13 | 一种检测猪萨佩罗病毒抗体的elisa试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106771237A CN106771237A (zh) | 2017-05-31 |
CN106771237B true CN106771237B (zh) | 2018-01-23 |
Family
ID=58876415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611145457.7A Active CN106771237B (zh) | 2016-12-13 | 2016-12-13 | 一种检测猪萨佩罗病毒抗体的elisa试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106771237B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019092027A1 (en) * | 2017-11-09 | 2019-05-16 | Boehringer Ingelheim Vetmedica Gmbh | Sapelovirus immunogenic compositions and uses thereof |
CN113604439B (zh) * | 2021-08-11 | 2023-05-26 | 扬州大学 | 一种抗猪萨佩罗病毒vp1蛋白杂交瘤细胞株、单克隆抗体及其应用 |
CN116162600B (zh) * | 2022-11-24 | 2024-07-05 | 上海市农业科学院 | 一种猪萨佩罗病毒细胞株、其培养方法及应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103173577A (zh) * | 2013-04-12 | 2013-06-26 | 上海交通大学 | 基于逆转录环介导等温扩增技术检测猪萨佩罗病毒的方法 |
CN104215762B (zh) * | 2014-09-28 | 2016-07-06 | 武汉中博生物股份有限公司 | 一种检测血清3型鸭甲型肝炎病毒抗体的间接elisa方法及试剂盒 |
CN105886496A (zh) * | 2014-10-28 | 2016-08-24 | 中华人民共和国北京出入境检验检疫局 | 间接elisa检测牛肠道病毒2型抗体的检测试剂盒 |
CN105675860A (zh) * | 2016-01-11 | 2016-06-15 | 吉林大学 | 检测e种肠道病毒抗体的诊断抗原vp1及试剂盒 |
CN106119263B (zh) * | 2016-06-21 | 2019-06-25 | 吉林大学 | G种肠道病毒诊断抗原及其试剂盒 |
-
2016
- 2016-12-13 CN CN201611145457.7A patent/CN106771237B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN106771237A (zh) | 2017-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111153991A (zh) | 一种人SARS-CoV-2单克隆抗体及其制备方法和应用 | |
CN113512110B (zh) | Bvdv纳米抗体及其制备方法及应用 | |
CN105440132B (zh) | 抗猪流行性腹泻病毒n蛋白的单克隆抗体及其应用 | |
CN115073613B (zh) | 一种融合蛋白GLuc-p30及其制备方法和应用 | |
CN104862285A (zh) | 猪流行性腹泻病毒抗体捕获elisa检测方法及应用 | |
CN114957454B (zh) | 一种抗csfv e2蛋白的纳米抗体、融合蛋白及其制备方法和应用 | |
CN105158480A (zh) | 用于检测小反刍兽疫病毒血凝素蛋白抗体的试剂盒及其使用方法 | |
CN106771237B (zh) | 一种检测猪萨佩罗病毒抗体的elisa试剂盒 | |
CN108715857A (zh) | 一种牛冠状病毒vpn基因、编码的重组蛋白及应用 | |
CN106442981B (zh) | 一种人博卡病毒1型抗体间接elisa诊断试剂盒 | |
CN103543261A (zh) | 牛羊布鲁氏菌病间接酶联免疫吸附试验抗体检测试剂盒及其制备方法 | |
CN105061602A (zh) | 用于检测抗猪产肠毒素性大肠杆菌抗体的融合蛋白、制备方法及应用 | |
CN104086657B (zh) | 用于联合检测EB病毒Rta蛋白抗体与EB病毒早期抗原EA抗体的人工抗原及试剂盒 | |
CN114778852B (zh) | 一种检测prrsv plp2抗体的间接elisa方法 | |
CN108982847B (zh) | 一种导致鸭脾脏坏死的鸭呼肠孤病毒的间接elisa检测方法 | |
CN104292311A (zh) | 用于检测猪流行性腹泻病毒中和抗体的抗原及其制备方法和应用 | |
CN107664694B (zh) | 一种基于e2蛋白检测猪非典型瘟病毒抗体的elisa试剂盒 | |
CN114276445A (zh) | 轮状病毒重组蛋白特异性抗体、质粒载体及方法 | |
CN110568189B (zh) | 犬腺病毒1型抗体elisa检测试剂盒及其应用 | |
CN105968196B (zh) | G种肠道病毒检测抗体双夹心elisa检测试剂盒 | |
CN109187952A (zh) | 一种猪非典型瘟病毒elisa抗体检测试剂盒 | |
CN110376385B (zh) | 一种基因工程表达qx型鸡传染性支气管炎病毒s1蛋白抗原的制备方法与应用 | |
CN102928605B (zh) | 一种检测类猪圆环病毒p1抗体的间接elisa试剂盒 | |
CN101979406B (zh) | 南非ⅱ型口蹄疫多抗原表位蛋白、其制备方法及应用 | |
CN105334322B (zh) | 一种水泡性口炎病毒重组n蛋白抗原及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |